Delivery Order SPE2DB22D1106-SPE2DB24FEUX7

Award Date 6/3/24
Potential Completion Date 6/25/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,491.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a completion date of February 13, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,994.89 firm fixed-price delivery order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $12,560.77, for the supply of LUMAKRAS 320 MG TABLET 90S, a specialty pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award is to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,559,458,471 units of the medication LUMAKRAS 120 MG TABLET 240S. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $23,687.42. The contract has an ultimate completion date of January 19, 2023 and was awarded on December 27, 2022. This award does not have...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,491.97, is for the supply of LUMAKRAS 320 MG TABLET 90S, a specialty pharmaceutical product, to support military healthcare programs. The contract is not designated as a set-aside and represents an Indefinite Delivery Contract (IDC) vehicle that AmerisourceBergen holds...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ03N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,121.56 Firm Fixed Price delivery order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $12,560.77 and an ultimate completion date of October 18, 2024. This award is a firm-fixed-price contract and is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a specialty pharmaceutical product, with a ceiling value of $13,304.34 and a period of performance through October 19, 2023. This contract is not set-aside and was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FDUR8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $12,560.77 and a completion date of February 2, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,044.98 firm fixed-price delivery order is for the supply of LAZCLUZE 240 MG TABLET 30S, a pharmaceutical product, with a performance period extending to February 3, 2025. The award is made under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical....
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEUX7
    Delivery Order

This federal contract award, worth $12,560.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a medical product, with a completion date of June 25, 2024.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with a Firm Fixed Price pricing type. This IDC, valued at $999,999,999, is a primary vehicle for DLA Troop Support Medical to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award did not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:37 PM